AMPK-regulated astrocytic lactate shuttle plays a non-cell-autonomous role in neuronal survival R Muraleedharan, MV Gawali, D Tiwari, A Sukumaran, N Oatman, ... Cell reports 32 (9), 2020 | 91 | 2020 |
Bone marrow regeneration requires mitochondrial transfer from donor Cx43-expressing hematopoietic progenitors to stroma K Golan, AK Singh, O Kollet, M Bertagna, MJ Althoff, E Khatib-Massalha, ... Blood, The Journal of the American Society of Hematology 136 (23), 2607-2619, 2020 | 64 | 2020 |
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer N Oatman, N Dasgupta, P Arora, K Choi, MV Gawali, N Gupta, ... Science Advances 7 (7), eabd7459, 2021 | 52 | 2021 |
Neuroprotective effect of Cubebin: A dibenzylbutyrolactone lignan on scopolamine-induced amnesia in mice GS Somani, MS Nahire, AD Parikh, MB Mulik, PJ Ghumatkar, KS Laddha, ... Indian journal of medical research 146 (2), 255-259, 2017 | 23 | 2017 |
Screening of Pistacia integerrima extracts for their anticonvulsant activity in acute zebrafish and rodent models of epilepsy PD Jain, RM Tambe, JS Sancheti, MS Nahire, AK Bhardwaj, S Sathaye International Journal of Nutrition, Pharmacology, Neurological Diseases 5 (2 …, 2015 | 19 | 2015 |
Brain pharmacokinetics and metabolism of the AMP-activated protein kinase selective inhibitor SBI-0206965, an investigational agent for the treatment of glioblastoma JM Desai, AS Karve, GA Gudelsky, MV Gawali, W Seibel, L Sallans, ... Investigational new drugs 40 (5), 944-952, 2022 | 7 | 2022 |
A Multimodal Drug–Diet–Immunotherapy Combination Restrains Melanoma Progression and Metastasis N Oatman, MV Gawali, S Congrove, R Cáceres, A Sukumaran, N Gupta, ... Cancer research 84 (14), 2333-2351, 2024 | 2 | 2024 |
EXTH-52. SYSTEMIC AND BRAIN PHARMACOKINETICS OF THE AMP-ACTIVATED PROTEIN KINASE SELECTIVE INHIBITOR SBI-0206965 AS A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF … J Desai, M Gawali, A Karve, G Gudelsky, L Sallans, B Dasgupta, W Seibel, ... Neuro-Oncology 23 (Supplement_6), vi175-vi175, 2021 | | 2021 |
SYSTEMIC AND BRAIN PHARMACOKINETICS OF THE AMP-ACTIVATED PROTEIN KINASE SELECTIVE INHIBITOR SBI-0206965 AS A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF GLIOBLASTOMA … J Desai, M Gawali, A Karve, G Gudelsky, L Sallans, B Dasgupta, W Seibel, ... NEURO-ONCOLOGY 23, 175-175, 2021 | | 2021 |
CBMT-05. GENETIC AND EPIGENETIC MECHANISMS REGULATING SCD INHIBITOR SENSITIVITY IN GLIOBLASTOMA N Oatman, N Dasgupta, B Dasgupta, K Choi, M Gawali, N Gupta, ... Neuro-Oncology 21 (Suppl 6), vi33, 2019 | | 2019 |
Neuroprotective Effects of Cubebin On Scopolamine-Induced Amnesia Via Anti-Acetylcholinesterase and Anti-Oxidative Activities in Mice MS Nahire, GS Somani, AD Parikh, MB Mulik, PJ Ghumatkar, KS Laddha, ... INDIAN JOURNAL OF PHARMACOLOGY 45, S100-S100, 2013 | | 2013 |